Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bentham

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Trials|October 25, 2013
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trialIracema Leroi, John Woolham, Rebecca Gathercole, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Journal of Alzheimer'S Disease : JAD|October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's DiseaseBjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
The Lancet. Psychiatry|June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Trials|October 25, 2013
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trialIracema Leroi, John Woolham, Rebecca Gathercole, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Journal of Alzheimer'S Disease : JAD|October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's DiseaseBjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
The Lancet. Psychiatry|June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Pageof 6